These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Erythropoietin-dependent autocrine secretion of tumor necrosis factor-alpha in hematopoietic cells modulates proliferation via MAP kinase--ERK-1/2 and does not require tyrosine docking sites in the EPO receptor. Chen J, Jacobs-Helber SM, Barber DL, Sawyer ST. Exp Cell Res; 2004 Aug 01; 298(1):155-66. PubMed ID: 15242770 [Abstract] [Full Text] [Related]
9. Expression of erythropoietin and its receptor in neuroblastomas. Sartelet H, Fabre M, Castaing M, Bosq J, Racu I, Lagonotte E, Scott V, Lecluse Y, Barette S, Michiels S, Vassal G. Cancer; 2007 Sep 01; 110(5):1096-106. PubMed ID: 17647284 [Abstract] [Full Text] [Related]
12. Erythropoietin receptor expression is concordant with erythropoietin but not with common beta chain expression in the rat brain throughout the life span. Sanchez PE, Navarro FP, Fares RP, Nadam J, Georges B, Moulin C, Le Cavorsin M, Bonnet C, Ryvlin P, Belmeguenai A, Bodennec J, Morales A, Bezin L. J Comp Neurol; 2009 Jun 01; 514(4):403-14. PubMed ID: 19330822 [Abstract] [Full Text] [Related]
13. Signaling pathways of cell proliferation are involved in the differential effect of erythropoietin and its carbamylated derivative. Chamorro ME, Wenker SD, Vota DM, Vittori DC, Nesse AB. Biochim Biophys Acta; 2013 Aug 01; 1833(8):1960-8. PubMed ID: 23602701 [Abstract] [Full Text] [Related]